|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 39.9 CHF | -2.44% |
|
-2.21% | +13.03% |
| 06-20 | Basilea Pharmaceutica to Sell Brain Cancer Drug Candidate to US-based Nonprofit | MT |
| 06-20 | Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation | DJ |
(MORE TO FOLLOW) Dow Jones Newswires
June 20, 2024 01:15 ET (05:15 GMT)
| 1st Jan change | Capi. | |
|---|---|---|
| +13.03% | 537M | |
| +23.13% | 46.93B | |
| +37.49% | 39.08B | |
| -8.73% | 38.48B | |
| +28.09% | 31.01B | |
| -12.26% | 26.14B | |
| +10.57% | 25.88B | |
| +45.05% | 14.15B | |
| +32.23% | 12.53B | |
| -6.56% | 11.36B |
BASILEA PHARMACEUTICA AG 
